Quantitative computed tomography detects interstitial lung diseases proven by biopsy.

Area of Science:

• Pulmonary Medicine
• Radiology
• Pathology

Background:

• Quantitative chest CT (QCT) shows promise for assessing interstitial lung disease (ILD).
• The correlation between QCT parameters and lung tissue fibrosis requires further investigation.
• This study aimed to compare QCT findings with histopathology in ILD patients.

Purpose of the Study:

• To compare QCT parameters with histopathological features in ILD patients.
• To determine if QCT assessment is consistent in patients with and without biopsy-proven ILD.
• To validate QCT as a tool for assessing pulmonary fibrosis.

Main Methods:

• Twenty ILD patients undergoing chest CT and lung biopsy were analyzed.
• Patients were categorized into biopsy-proven idiopathic pulmonary fibrosis (bIPF) and sarcoidosis (bSarc) groups.
• A control group of 20 patients with a radiological diagnosis of IPF (rIPF) was included for comparison.

Main Results:

• No significant differences in gender, smoking habits, or spirometry were found between groups.
• The rIPF group was older than the bIPF and bSarc groups (p<0.001).
• QCT parameters differed significantly between bIPF and bSarc (p<0.01) but were comparable between bIPF and rIPF.

Conclusions:

• QCT parameters are consistent for the same ILD type, whether diagnosed via biopsy or CT alone.
• These findings support QCT's capability to detect pulmonary fibrosis.
• QCT is a valuable and effective tool for assessing ILD.